Meiragtx Holdings plc insider trading
Every open-market purchase and sale by Meiragtx Holdings plc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Meiragtx Holdings plc’s insiders pay?
From March 5, 2019 to August 14, 2024, 6 insiders reported 7 open-market purchases and 2 sales not made under a pre-set plan in Meiragtx Holdings plc. Twelve months after each purchase was reported, the shares were −27.6% against the S&P 500 on average (median −27.9%), over 6 purchases with a full year of prices; 17% beat the index. After sales, the shares moved −42.9% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 6, 2019 into $7,037 by November 2, 2026, −4.5% a year. It held shares 61% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $24,974 (+12.7% a year), and held throughout $30,568 (+15.7%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Edelman Joseph | Director | 2 | −55.0% (1) | 0% | 0 | — | August 14, 2024 |
| Marcus Joel S | Director | 0 | — | — | 2 | −42.9% (2) | August 12, 2020 |
| Perceptive Life Sciences Master Fund Ltd | Director | 2 | −31.6% (2) | 0% | 0 | — | May 15, 2023 |
| Perceptive Advisors LLC | Director | 1 | +2.4% (1) | 100% | 0 | — | November 24, 2020 |
| Seligman Nicole | Director | 1 | −42.3% (1) | 0% | 0 | — | November 20, 2019 |
| Zeldin Robert K | CHIEF MEDICAL OFFICER | 1 | −7.5% (1) | 0% | 0 | — | June 6, 2022 |